董事介绍

注:董事持股数取自最新公司公告

姓名 性别 职位 年龄 薪酬 持股数(万股) 截止日期
Delos Cosgrove Director 85 5.00万美元 未持股 2025-11-02
Christopher Payne Director 56 未披露 未持股 2025-11-02
Andrew Dudum Chief Executive Officer, Director and Chairman 36 2657.58万美元 未持股 2025-11-02
Andrea Perez Director 44 未披露 未持股 2025-11-02
David Wells Lead Independent Director 53 136.79万美元 未持股 2025-11-02
Deb Autor Director 58 未披露 未持股 2025-11-02
Anja Manuel Director 50 未披露 未持股 2025-11-02
Christiane Pendarvis Director 55 未披露 未持股 2025-11-02
Kre Schultz Director 63 未披露 未持股 2025-11-02
Patrick Carroll Chief Medical Officer and Director 66 未披露 未持股 2025-11-02

高管介绍

注:高管持股数取自最新公司公告

姓名 性别 职位 年龄 薪酬 持股数(万股) 截止日期
Andrew Dudum Chief Executive Officer, Director and Chairman 36 2657.58万美元 未持股 2025-11-02
Melissa Baird Chief Operating Officer 47 434.65万美元 未持股 2025-11-02
Soleil Boughton Chief Legal Officer 47 未披露 未持股 2025-11-02
Yemi Okupe Chief Financial Officer 39 未披露 未持股 2025-11-02
Mike Chi Chief Operating Officer 46 未披露 未持股 2025-11-02
Patrick Carroll Chief Medical Officer and Director 66 未披露 未持股 2025-11-02

董事简历

中英对照 |  中文 |  英文
Delos Cosgrove

Delos Cosgrove曾担任克利夫兰诊所的执行顾问,并自2018年7月起担任Google Cloud梦百合和生命科学团队的执行顾问。2004年至2017年,Cosgrove博士担任克利夫兰诊所(Cleveland Clinic)的首席执行官兼总裁。在加入克利夫兰诊所(Cleveland Clinic)之前,他是美国空军的一名外科医生,获得铜星勋章。他发表了近450篇期刊文章和书籍章节,拥有30项医疗创新专利。他是16个科学协会的成员,连续三届总统政府都就梦百合问题征求过他的意见。Cosgrove博士拥有威廉姆斯学院(Williams College)的学士学位和弗吉尼亚大学医学院(University of Virginia School of Medicine)的医学博士学位。他在Massachusetts General Hospital和Brook General Hospital完成了临床培训。


Delos Cosgrove,has served on Board of Directors since the consummation of the Business Combination. Dr. Cosgrove was a board observer for Hims, Inc. from October 2019 until formally becoming a member of Board of Directors in September 2020. Dr. Cosgrove has served as an Executive Advisor for The Cleveland Clinic since December 2017, where he was the President and Chief Executive Officer from January 2004 through December 2017. He has served as a director of American Well Corp. (Amwell), a telemedicine company, since 2019, and was a director of View, Inc., glass-manufacturing company specializing in the production of smart glass, from March 2021 through August 2024. He also currently serves as a member of the board of directors of several privately held companies. Dr. Cosgrove obtained a B.A. in Biology from Williams College and an M.D. from University of Virginia School of Medicine. He served as Chief of USAF in the Casualty Staging Flight in Da Nang, Republic of Vietnam, and as a surgeon at Hamilton AFB in California. He also received medical training at various hospitals in the U.S. and abroad.
Delos Cosgrove曾担任克利夫兰诊所的执行顾问,并自2018年7月起担任Google Cloud梦百合和生命科学团队的执行顾问。2004年至2017年,Cosgrove博士担任克利夫兰诊所(Cleveland Clinic)的首席执行官兼总裁。在加入克利夫兰诊所(Cleveland Clinic)之前,他是美国空军的一名外科医生,获得铜星勋章。他发表了近450篇期刊文章和书籍章节,拥有30项医疗创新专利。他是16个科学协会的成员,连续三届总统政府都就梦百合问题征求过他的意见。Cosgrove博士拥有威廉姆斯学院(Williams College)的学士学位和弗吉尼亚大学医学院(University of Virginia School of Medicine)的医学博士学位。他在Massachusetts General Hospital和Brook General Hospital完成了临床培训。
Delos Cosgrove,has served on Board of Directors since the consummation of the Business Combination. Dr. Cosgrove was a board observer for Hims, Inc. from October 2019 until formally becoming a member of Board of Directors in September 2020. Dr. Cosgrove has served as an Executive Advisor for The Cleveland Clinic since December 2017, where he was the President and Chief Executive Officer from January 2004 through December 2017. He has served as a director of American Well Corp. (Amwell), a telemedicine company, since 2019, and was a director of View, Inc., glass-manufacturing company specializing in the production of smart glass, from March 2021 through August 2024. He also currently serves as a member of the board of directors of several privately held companies. Dr. Cosgrove obtained a B.A. in Biology from Williams College and an M.D. from University of Virginia School of Medicine. He served as Chief of USAF in the Casualty Staging Flight in Da Nang, Republic of Vietnam, and as a surgeon at Hamilton AFB in California. He also received medical training at various hospitals in the U.S. and abroad.
Christopher Payne

Christopher Payne自2016年1月起担任Doordash, Inc.的首席运营官。加入Doordash, Inc.之前,Payne先生于2015年3月至2015年8月担任Tinder,Inc.的首席执行官。2009年1月至2014年12月,他在eBay Inc.任职,eBay Inc.是一家在线市场和支付公司,2010年9月至2014年12月担任北美高级副总裁,2009年1月至2010年9月担任采购经验副总裁。Payne先生曾担任机器学习公司Positronic,Inc.的创始人和首席执行官,从2007年7月到2008年12月,Payne先生被出售给eBay公司。他目前是Gogo公司的董事会成员,Gogo公司是一家航空通信服务提供商。Payne先生拥有达特茅斯学院的美国历史学士学位。


Christopher Payne has served as Doordash, Inc. Chief Operating Officer since January 2016 and Doordash, Inc. President since May 2021. Prior to joining Doordash, Inc., Mr. Payne served as Chief Executive Officer of Tinder, Inc., a social search mobile application, from March 2015 to August 2015. From January 2009 to December 2014 he was with eBay Inc., an online marketplace and payments company, where he served as Senior Vice President, North America from September 2010 to December 2014 and Vice President Buyer Experience from January 2009 to September 2010. Mr. Payne served as the founder and Chief Executive Officer of Positronic, Inc., a machine learning company, from July 2007 until December 2008 when it was sold to eBay Inc. Mr. Payne currently serves on the board of directors of Gogo Inc., an aero communications service provider. Mr. Payne holds a B.A. in U.S. History from Dartmouth College.
Christopher Payne自2016年1月起担任Doordash, Inc.的首席运营官。加入Doordash, Inc.之前,Payne先生于2015年3月至2015年8月担任Tinder,Inc.的首席执行官。2009年1月至2014年12月,他在eBay Inc.任职,eBay Inc.是一家在线市场和支付公司,2010年9月至2014年12月担任北美高级副总裁,2009年1月至2010年9月担任采购经验副总裁。Payne先生曾担任机器学习公司Positronic,Inc.的创始人和首席执行官,从2007年7月到2008年12月,Payne先生被出售给eBay公司。他目前是Gogo公司的董事会成员,Gogo公司是一家航空通信服务提供商。Payne先生拥有达特茅斯学院的美国历史学士学位。
Christopher Payne has served as Doordash, Inc. Chief Operating Officer since January 2016 and Doordash, Inc. President since May 2021. Prior to joining Doordash, Inc., Mr. Payne served as Chief Executive Officer of Tinder, Inc., a social search mobile application, from March 2015 to August 2015. From January 2009 to December 2014 he was with eBay Inc., an online marketplace and payments company, where he served as Senior Vice President, North America from September 2010 to December 2014 and Vice President Buyer Experience from January 2009 to September 2010. Mr. Payne served as the founder and Chief Executive Officer of Positronic, Inc., a machine learning company, from July 2007 until December 2008 when it was sold to eBay Inc. Mr. Payne currently serves on the board of directors of Gogo Inc., an aero communications service provider. Mr. Payne holds a B.A. in U.S. History from Dartmouth College.
Andrew Dudum

Andrew Dudum,自业务合并完成以来,Dudum先生一直担任我们的首席执行官和董事会主席。Dudum先生是HIMS的联合创始人,自2016年9月以来一直担任HIMS的首席执行官兼董事。Dudum先生是Startup Studio和投资基金Atomic Labs,LLC的联合创始人兼普通合伙人,自2013年以来,他在该公司联合创立了十几家公司,包括Bungalow,Homebound,Talkiq和Terminal。Dudum先生是一位连续创始人,活跃的天使投资者和各种创业公司的顾问。杜杜杜姆是总部位于中国和美国的早期风险投资公司Cherubic Ventures的顾问,并于2020年被《财富》杂志评为40岁以下40人名单。Dudum先生在宾夕法尼亚大学沃顿商学院获得管理和经济学学士学位。


Andrew Dudum,has served as Chief Executive Officer and Chairman of Board of Directors since the consummation of the business combination that resulted in Hims & Hers becoming a publicly traded company (the "Business Combination"). He is co-founder and has been the Chief Executive Officer and a director of Hims, Inc. since September 2016. Mr. Dudum is a co-founder of startup studio and investment fund Atomic Labs, LLC, since 2013, where he has co-founded over a dozen companies including Bungalow, Homebound, TalkIQ, and Terminal. He is a serial founder, active angel investor and advisor to various startup companies, including Cherubic Ventures, a China and U.S. based early-stage venture capital firm. Mr. Dudum received a B.A. in Management and Economics from the Wharton School at the University of Pennsylvania.
Andrew Dudum,自业务合并完成以来,Dudum先生一直担任我们的首席执行官和董事会主席。Dudum先生是HIMS的联合创始人,自2016年9月以来一直担任HIMS的首席执行官兼董事。Dudum先生是Startup Studio和投资基金Atomic Labs,LLC的联合创始人兼普通合伙人,自2013年以来,他在该公司联合创立了十几家公司,包括Bungalow,Homebound,Talkiq和Terminal。Dudum先生是一位连续创始人,活跃的天使投资者和各种创业公司的顾问。杜杜杜姆是总部位于中国和美国的早期风险投资公司Cherubic Ventures的顾问,并于2020年被《财富》杂志评为40岁以下40人名单。Dudum先生在宾夕法尼亚大学沃顿商学院获得管理和经济学学士学位。
Andrew Dudum,has served as Chief Executive Officer and Chairman of Board of Directors since the consummation of the business combination that resulted in Hims & Hers becoming a publicly traded company (the "Business Combination"). He is co-founder and has been the Chief Executive Officer and a director of Hims, Inc. since September 2016. Mr. Dudum is a co-founder of startup studio and investment fund Atomic Labs, LLC, since 2013, where he has co-founded over a dozen companies including Bungalow, Homebound, TalkIQ, and Terminal. He is a serial founder, active angel investor and advisor to various startup companies, including Cherubic Ventures, a China and U.S. based early-stage venture capital firm. Mr. Dudum received a B.A. in Management and Economics from the Wharton School at the University of Pennsylvania.
Andrea Perez

Andrea Perez于2021年3月加入我们的董事会。佩雷斯女士自2017年10月起担任耐克品牌乔丹&;8217;S女装&;8217;S部门的全球副总裁兼总经理。在担任这一职务之前,她在耐克担任过其他几个职位,包括2017年10月至2020年6月担任乔丹儿童副总裁/总经理;2014年11月至2017年10月担任北美足球总经理;以及全球足球高级品牌总监2011年12月至2014年11月担任网球全球品牌总监。在加入耐克之前,Perez女士在几家领先的体育和健身公司担任过各种职务。佩雷斯女士是耐克女性员工集团的联合创始人,目前担任女性体育基金会治理委员会主席。她还在食品和技术领域的几个本地和全球初创企业的咨询委员会任职。佩雷斯女士获得了Tecnologico de Monterrey的营销学士学位和达特茅斯大学塔克商学院的工商管理硕士学位,并获得了Julia Stell杰出领导奖。


Andrea Perez,joined Board of Directors in March 2021. Ms. Perez was the Senior Vice President of Brand, Products and Services Marketing of Sony Interactive Entertainment from September 2022 to April 2024. She was previously the Global Vice President and General Manager for Brand Jordan's Women's Division at Nike, a position she held from October 2017 through September 2022. During her tenure at Nike, she held several positions, including VP/GM for Jordan Kids; General Manager for North America Soccer from November; and Senior Brand Director for Global Football (soccer) and Global Brand Director for Tennis. Ms. Perez was a co-founder of the Women of Nike employee group, and served as chair of the governance committee for the Women's Sport Foundation. She also serves on several advisory boards for national and global start-ups in the services and technology sector. Ms. Perez received a B.A. in Marketing from Tecnologico de Monterrey and an M.B.A. from Dartmouth's Tuck School of Business, with a Julia Stell Award for Outstanding Leadership.
Andrea Perez于2021年3月加入我们的董事会。佩雷斯女士自2017年10月起担任耐克品牌乔丹&;8217;S女装&;8217;S部门的全球副总裁兼总经理。在担任这一职务之前,她在耐克担任过其他几个职位,包括2017年10月至2020年6月担任乔丹儿童副总裁/总经理;2014年11月至2017年10月担任北美足球总经理;以及全球足球高级品牌总监2011年12月至2014年11月担任网球全球品牌总监。在加入耐克之前,Perez女士在几家领先的体育和健身公司担任过各种职务。佩雷斯女士是耐克女性员工集团的联合创始人,目前担任女性体育基金会治理委员会主席。她还在食品和技术领域的几个本地和全球初创企业的咨询委员会任职。佩雷斯女士获得了Tecnologico de Monterrey的营销学士学位和达特茅斯大学塔克商学院的工商管理硕士学位,并获得了Julia Stell杰出领导奖。
Andrea Perez,joined Board of Directors in March 2021. Ms. Perez was the Senior Vice President of Brand, Products and Services Marketing of Sony Interactive Entertainment from September 2022 to April 2024. She was previously the Global Vice President and General Manager for Brand Jordan's Women's Division at Nike, a position she held from October 2017 through September 2022. During her tenure at Nike, she held several positions, including VP/GM for Jordan Kids; General Manager for North America Soccer from November; and Senior Brand Director for Global Football (soccer) and Global Brand Director for Tennis. Ms. Perez was a co-founder of the Women of Nike employee group, and served as chair of the governance committee for the Women's Sport Foundation. She also serves on several advisory boards for national and global start-ups in the services and technology sector. Ms. Perez received a B.A. in Marketing from Tecnologico de Monterrey and an M.B.A. from Dartmouth's Tuck School of Business, with a Julia Stell Award for Outstanding Leadership.
David Wells

David Wells,自业务合并完成以来,Wells先生一直在我们的董事会任职。自2020年9月以来,Wells先生一直是HIMS的董事会成员。Wells先生被认为是财务专家,曾担任上市公司首席财务官和审计委员会主席。他最近从2010年12月至2019年1月担任Netflix首席财务官8年。在Netflix工作期间,Wells先生担任财务规划与分析的总体负责人,从2015年7月到2017年7月,他在荷兰居住并履行职责,这是建立Netflix欧洲业务的一部分。他目前担任The Trade Desk(上市公司,为广告买家提供技术平台)的董事会成员,于2015年12月加入该公司,并担任审计委员会主席和薪酬委员会成员,以及TransferWise(一家私人技术公司),他于2019年1月加入董事会,担任董事会联席主席。Wells先生在弗吉尼亚大学获得商业和英语学士学位,并在芝加哥大学以优异成绩获得M.B.A./M.P.P.硕士学位。


David Wells,has served on Board of Directors since the consummation of the Business Combination and served on the Board of Directors of Hims, Inc. from September 2020 through January 2021. Mr. Wells is considered an audit committee financial expert, having served as a public company Chief Financial Officer and audit committee chair. He most recently served as the Chief Financial Officer of Netflix from December 2010 to January 2019. During his time at Netflix, Mr. Wells served as overall head of Financial Planning & Analysis and spent two years, from July 2015 to July 2017, in the Netherlands as part of the build-up of Netflix's European operations. Since 2015, he has served on the board of directors of Trade Desk, Inc., a public company that provides a technology platform for advertising buyers, and is the audit committee chair and a member of its compensation committee. Mr. Wells has served as a board member of Wise PLC, a company specializing in instant cross-border money transfer, since 2019, where he is Chair of the Board (formerly Senior Independent Director) and has served on the Audit & Risk and the Remuneration (Compensation) Committees. Mr. Wells received a B.S. in Commerce and English from the University of Virginia and an M.B.S./M.P.P. Magna Cum Laude from the University of Chicago.
David Wells,自业务合并完成以来,Wells先生一直在我们的董事会任职。自2020年9月以来,Wells先生一直是HIMS的董事会成员。Wells先生被认为是财务专家,曾担任上市公司首席财务官和审计委员会主席。他最近从2010年12月至2019年1月担任Netflix首席财务官8年。在Netflix工作期间,Wells先生担任财务规划与分析的总体负责人,从2015年7月到2017年7月,他在荷兰居住并履行职责,这是建立Netflix欧洲业务的一部分。他目前担任The Trade Desk(上市公司,为广告买家提供技术平台)的董事会成员,于2015年12月加入该公司,并担任审计委员会主席和薪酬委员会成员,以及TransferWise(一家私人技术公司),他于2019年1月加入董事会,担任董事会联席主席。Wells先生在弗吉尼亚大学获得商业和英语学士学位,并在芝加哥大学以优异成绩获得M.B.A./M.P.P.硕士学位。
David Wells,has served on Board of Directors since the consummation of the Business Combination and served on the Board of Directors of Hims, Inc. from September 2020 through January 2021. Mr. Wells is considered an audit committee financial expert, having served as a public company Chief Financial Officer and audit committee chair. He most recently served as the Chief Financial Officer of Netflix from December 2010 to January 2019. During his time at Netflix, Mr. Wells served as overall head of Financial Planning & Analysis and spent two years, from July 2015 to July 2017, in the Netherlands as part of the build-up of Netflix's European operations. Since 2015, he has served on the board of directors of Trade Desk, Inc., a public company that provides a technology platform for advertising buyers, and is the audit committee chair and a member of its compensation committee. Mr. Wells has served as a board member of Wise PLC, a company specializing in instant cross-border money transfer, since 2019, where he is Chair of the Board (formerly Senior Independent Director) and has served on the Audit & Risk and the Remuneration (Compensation) Committees. Mr. Wells received a B.S. in Commerce and English from the University of Virginia and an M.B.S./M.P.P. Magna Cum Laude from the University of Chicago.
Deb Autor

Deb Autor,是Healthcare Innovation Catalysts的首席执行官,Healthcare Innovation Catalysts是一家为全球生命科学组织提供监管事务、临床咨询、质量、合规、联邦合作伙伴关系和战略咨询服务的提供商;并担任FDA校友协会董事会主席。Autor女士还曾担任监管科学创新中心的科学咨询委员会成员,以及抗菌素耐药性产业联盟、美国药典质量研究所和肠外用药协会的董事会成员。从2019年至2021年,Autor女士担任阿斯利康卓越监管全球负责人,领导了全球所有阿斯利康产品的多项监管职能。在加入阿斯利康之前,Autor女士于2013-2019年在Mylan N.V.任职,担任战略全球质量和监管政策主管以及全球质量主管。Autor曾在2001-2013年期间担任FDA的高级领导,最近担任全球监管运营和政策副专员,负责监督FDA对人类和兽药、生物制剂、医疗设备、烟草和食品的所有检查、刑事调查和国际业务。在此之前,Autor女士担任药品审评研究中心合规办公室主任,领导遵守所有药品要求的执法和政策制定,包括药品批准;现行良好生产规范(GMP);人类受试者保护和生物研究监测(GCP);进出口;以及召回。在加入FDA之前,Autor女士是美国司法部消费者诉讼办公室的一名审判律师,在那里她代表FDA处理民事和刑事案件。


Deb Autor,is CEO of Healthcare Innovation Catalysts, a provider of regulatory affairs, clinical advisory, quality, compliance, federal partnership, and strategic advisory services to global life sciences organizations; and Chair of the Board of the FDA Alumni Association. Ms. Autor has also served as a Scientific Advisory Council Member of the Centre for Innovation in Regulatory Science and as a Board Member of the Antimicrobial Resistance Industry Alliance, the United States Pharmacopoeia Quality Institute, and the Parenteral Drug Association.From 2019-2021, Ms. Autor was Global Head of Regulatory Excellence at AstraZeneca, where she led multiple regulatory functions for all AstraZeneca products globally. Before joining AstraZeneca, Ms. Autor served at Mylan N.V. from 2013-2019, where she was Head of Strategic Global Quality and Regulatory Policy and Head of Global Quality.Ms. Autor was a senior leader at FDA from 2001-2013, most recently as Deputy Commissioner for Global Regulatory Operations and Policy where she oversaw all FDA inspections, criminal investigations and international operations for human and veterinary drugs, biologics, medical devices, tobacco and food. Before that, Ms. Autor served as Director of the Office of Compliance of the Center for Drug Evaluation and Research, leading enforcement and policy making for compliance with all drug requirements, including drug approval; current good manufacturing practices (GMP); human subject protection and bioresearch monitoring (GCP); import and export; and recalls. Before joining FDA, Ms. Autor was a Trial Attorney in the Office of Consumer Litigation of the U.S. Department of Justice, where she litigated civil and criminal cases on behalf of FDA.
Deb Autor,是Healthcare Innovation Catalysts的首席执行官,Healthcare Innovation Catalysts是一家为全球生命科学组织提供监管事务、临床咨询、质量、合规、联邦合作伙伴关系和战略咨询服务的提供商;并担任FDA校友协会董事会主席。Autor女士还曾担任监管科学创新中心的科学咨询委员会成员,以及抗菌素耐药性产业联盟、美国药典质量研究所和肠外用药协会的董事会成员。从2019年至2021年,Autor女士担任阿斯利康卓越监管全球负责人,领导了全球所有阿斯利康产品的多项监管职能。在加入阿斯利康之前,Autor女士于2013-2019年在Mylan N.V.任职,担任战略全球质量和监管政策主管以及全球质量主管。Autor曾在2001-2013年期间担任FDA的高级领导,最近担任全球监管运营和政策副专员,负责监督FDA对人类和兽药、生物制剂、医疗设备、烟草和食品的所有检查、刑事调查和国际业务。在此之前,Autor女士担任药品审评研究中心合规办公室主任,领导遵守所有药品要求的执法和政策制定,包括药品批准;现行良好生产规范(GMP);人类受试者保护和生物研究监测(GCP);进出口;以及召回。在加入FDA之前,Autor女士是美国司法部消费者诉讼办公室的一名审判律师,在那里她代表FDA处理民事和刑事案件。
Deb Autor,is CEO of Healthcare Innovation Catalysts, a provider of regulatory affairs, clinical advisory, quality, compliance, federal partnership, and strategic advisory services to global life sciences organizations; and Chair of the Board of the FDA Alumni Association. Ms. Autor has also served as a Scientific Advisory Council Member of the Centre for Innovation in Regulatory Science and as a Board Member of the Antimicrobial Resistance Industry Alliance, the United States Pharmacopoeia Quality Institute, and the Parenteral Drug Association.From 2019-2021, Ms. Autor was Global Head of Regulatory Excellence at AstraZeneca, where she led multiple regulatory functions for all AstraZeneca products globally. Before joining AstraZeneca, Ms. Autor served at Mylan N.V. from 2013-2019, where she was Head of Strategic Global Quality and Regulatory Policy and Head of Global Quality.Ms. Autor was a senior leader at FDA from 2001-2013, most recently as Deputy Commissioner for Global Regulatory Operations and Policy where she oversaw all FDA inspections, criminal investigations and international operations for human and veterinary drugs, biologics, medical devices, tobacco and food. Before that, Ms. Autor served as Director of the Office of Compliance of the Center for Drug Evaluation and Research, leading enforcement and policy making for compliance with all drug requirements, including drug approval; current good manufacturing practices (GMP); human subject protection and bioresearch monitoring (GCP); import and export; and recalls. Before joining FDA, Ms. Autor was a Trial Attorney in the Office of Consumer Litigation of the U.S. Department of Justice, where she litigated civil and criminal cases on behalf of FDA.
Anja Manuel

Anja Manuel,于2024年4月加入董事会。Manuel女士是Rice,Hadley,Gates & Manuel LLC的联合创始人和合伙人,Rice,Hadley,Gates & Manuel LLC是一家战略咨询公司,成立于2009年,帮助美国公司应对国际监管问题并拓展国际市场。自2022年1月起,她还担任阿斯彭战略集团和阿斯彭安全论坛的执行董事,该论坛是美国首要的外交政策两党论坛。此前,她曾在美国国务院担任官员,在WilmerHale担任律师,并在所罗门兄弟公司担任投资银行家。Manuel女士在2009年至2019年和2024年期间一直在斯坦福大学讲课并担任研究附属机构,教授有关美国在亚洲的外交政策和技术政策的课程。她是Simon和Schuster于2016年出版的广受好评的著作《这个勇敢的新世界:印度、中国和美国》的作者,以及众多文章和论文。Manuel女士于2017年6月至2023年6月期间担任上市运输公司Overseas Shipping Group,Inc.的董事会成员。自2017年8月以来,她目前担任私有区块链支付公司Ripple Labs,Inc.的董事会成员,并且是包括美国国防部政策委员会在内的多个私营公司、基金会和政府实体顾问委员会的成员。Manuel女士在斯坦福大学获得国际政策研究硕士和学士学位,在哈佛法学院获得法学博士学位。


Anja Manuel,joined Board of Directors in April 2024. Ms. Manuel is the co-founder of and a partner in Rice, Hadley, Gates & Manuel LLC, a strategic consulting firm founded in 2009 that helps US companies navigate international regulatory issues and expand into international markets. She has also served as the Executive Director of the Aspen Strategy Group and Aspen Security Forum, a premier bi-partisan forum on foreign policy in the U.S, since January 2022. She previously served as an official in the U.S. State Department, as an attorney at WilmerHale, and as an investment banker at Salomon Brothers. Ms. Manuel lectured ad was a research affiliate at Stanford University from 2009 to 2019 and 2024 through the present, teaching courses on U.S. Foreign Policy in Asia and Technology Policy. She is the author of the critically acclaimed book "This Brave New World: India, China and the United States," published by Simon and Schuster in 2016, and numerous articles and papers. Ms. Manuel served as a member of the board of directors of Overseas Shipping Group, Inc., a publicly traded transportation company, from June 2017 to June 2023. She currently serves on the board of directors of Ripple Labs, Inc., a privately held blockchain payments company, since August 2017 and is a member of several advisory boards of private companies, foundations and governmental entities, including the U.S. Defense Department Policy Board. Ms. Manuel received an MA and BA in International Policy Studies from Stanford University and a J.D. from Harvard Law School.
Anja Manuel,于2024年4月加入董事会。Manuel女士是Rice,Hadley,Gates & Manuel LLC的联合创始人和合伙人,Rice,Hadley,Gates & Manuel LLC是一家战略咨询公司,成立于2009年,帮助美国公司应对国际监管问题并拓展国际市场。自2022年1月起,她还担任阿斯彭战略集团和阿斯彭安全论坛的执行董事,该论坛是美国首要的外交政策两党论坛。此前,她曾在美国国务院担任官员,在WilmerHale担任律师,并在所罗门兄弟公司担任投资银行家。Manuel女士在2009年至2019年和2024年期间一直在斯坦福大学讲课并担任研究附属机构,教授有关美国在亚洲的外交政策和技术政策的课程。她是Simon和Schuster于2016年出版的广受好评的著作《这个勇敢的新世界:印度、中国和美国》的作者,以及众多文章和论文。Manuel女士于2017年6月至2023年6月期间担任上市运输公司Overseas Shipping Group,Inc.的董事会成员。自2017年8月以来,她目前担任私有区块链支付公司Ripple Labs,Inc.的董事会成员,并且是包括美国国防部政策委员会在内的多个私营公司、基金会和政府实体顾问委员会的成员。Manuel女士在斯坦福大学获得国际政策研究硕士和学士学位,在哈佛法学院获得法学博士学位。
Anja Manuel,joined Board of Directors in April 2024. Ms. Manuel is the co-founder of and a partner in Rice, Hadley, Gates & Manuel LLC, a strategic consulting firm founded in 2009 that helps US companies navigate international regulatory issues and expand into international markets. She has also served as the Executive Director of the Aspen Strategy Group and Aspen Security Forum, a premier bi-partisan forum on foreign policy in the U.S, since January 2022. She previously served as an official in the U.S. State Department, as an attorney at WilmerHale, and as an investment banker at Salomon Brothers. Ms. Manuel lectured ad was a research affiliate at Stanford University from 2009 to 2019 and 2024 through the present, teaching courses on U.S. Foreign Policy in Asia and Technology Policy. She is the author of the critically acclaimed book "This Brave New World: India, China and the United States," published by Simon and Schuster in 2016, and numerous articles and papers. Ms. Manuel served as a member of the board of directors of Overseas Shipping Group, Inc., a publicly traded transportation company, from June 2017 to June 2023. She currently serves on the board of directors of Ripple Labs, Inc., a privately held blockchain payments company, since August 2017 and is a member of several advisory boards of private companies, foundations and governmental entities, including the U.S. Defense Department Policy Board. Ms. Manuel received an MA and BA in International Policy Studies from Stanford University and a J.D. from Harvard Law School.
Christiane Pendarvis

Christiane Pendarvis,于2023年2月加入董事会。她目前是PatterN Beauty的联席首席执行官,这是一家消费零售护发公司,其产品专为卷曲、卷曲和质地紧致的头发设计。在加入PATTEN之前,2020年1月至2023年6月,她担任Savage X Fenty的联席总裁/首席营销与设计官,这是一个直接面向消费者(DTC)的贴身衣物、家居服和运动服品牌,服务于男性和女性。2018年4月至2020年1月,她担任FullBeauty Brands的电子商务和市场高级副总裁,FullBeauty Brands是一家服务于女性大码和男性高大上市场的多品牌DTC零售商。在加入FullBeauty之前,她曾在Charming Charlie、Minted、Gap Inc.、American Eagle和Victoria's Secret担任过多个领导职务。自2021年10月以来,她一直是私营社交媒体管理平台Hootsuite的董事会成员,担任该平台的治理和提名委员会主席以及审计委员会成员。Pendarvis女士拥有哈佛大学经济学学士学位和UNC Kenan-Flagler商学院工商管理硕士学位。


Christiane Pendarvis,joined Board of Directors in February 2023. She is currently the Co-Chief Executive Officer of PATTERN Beauty, a consumer retail hair care company with products designed for curly, coily and tight-textured hair. Prior to joining PATTERN, from January 2020 to June 2023, she served as Co-President/Chief Merchandising & Design Officer for Savage X Fenty, a direct-to-consumer (DTC) intimate apparel, loungewear and activewear brand serving men and women. She was SVP, E-commerce and Marketplaces for FullBeauty Brands, a multi-brand DTC retailer serving the women's plus size and men's big and tall market, from April 2018 to Jan 2020. Prior to her tenure at FullBeauty, she held various leadership roles at Charming Charlie, Minted, Gap Inc., American Eagle and Victoria's Secret. She has been a board member of Hootsuite, a privately-held social media management platform, since October 2021, where she is chair of the Governance and Nomination Committee and a member of the Audit Committee. Ms. Pendarvis holds a B.A. in Economics from Harvard University and an M.B.A. from UNC Kenan-Flagler Business School.
Christiane Pendarvis,于2023年2月加入董事会。她目前是PatterN Beauty的联席首席执行官,这是一家消费零售护发公司,其产品专为卷曲、卷曲和质地紧致的头发设计。在加入PATTEN之前,2020年1月至2023年6月,她担任Savage X Fenty的联席总裁/首席营销与设计官,这是一个直接面向消费者(DTC)的贴身衣物、家居服和运动服品牌,服务于男性和女性。2018年4月至2020年1月,她担任FullBeauty Brands的电子商务和市场高级副总裁,FullBeauty Brands是一家服务于女性大码和男性高大上市场的多品牌DTC零售商。在加入FullBeauty之前,她曾在Charming Charlie、Minted、Gap Inc.、American Eagle和Victoria's Secret担任过多个领导职务。自2021年10月以来,她一直是私营社交媒体管理平台Hootsuite的董事会成员,担任该平台的治理和提名委员会主席以及审计委员会成员。Pendarvis女士拥有哈佛大学经济学学士学位和UNC Kenan-Flagler商学院工商管理硕士学位。
Christiane Pendarvis,joined Board of Directors in February 2023. She is currently the Co-Chief Executive Officer of PATTERN Beauty, a consumer retail hair care company with products designed for curly, coily and tight-textured hair. Prior to joining PATTERN, from January 2020 to June 2023, she served as Co-President/Chief Merchandising & Design Officer for Savage X Fenty, a direct-to-consumer (DTC) intimate apparel, loungewear and activewear brand serving men and women. She was SVP, E-commerce and Marketplaces for FullBeauty Brands, a multi-brand DTC retailer serving the women's plus size and men's big and tall market, from April 2018 to Jan 2020. Prior to her tenure at FullBeauty, she held various leadership roles at Charming Charlie, Minted, Gap Inc., American Eagle and Victoria's Secret. She has been a board member of Hootsuite, a privately-held social media management platform, since October 2021, where she is chair of the Governance and Nomination Committee and a member of the Audit Committee. Ms. Pendarvis holds a B.A. in Economics from Harvard University and an M.B.A. from UNC Kenan-Flagler Business School.
Kre Schultz

K re Schultz,自2024年7月起担任董事会成员。2017年11月至2023年1月,Schultz先生担任梯瓦制药有限公司的首席执行官和董事。2015年至2017年10月,Schultz先生担任H. Lundbeck A/S总裁兼首席执行官。在加入Lundbeck之前,Schultz先生在诺和诺德工作了近三十年,担任过多个领导职务,包括糖尿病护理部门的首席运营官、产品供应副总裁以及产品规划和客户服务总监,他在公司大规模生物制剂生产的现代化和引领公司向美国和中国市场的扩张方面发挥了重要作用。除了在诺和诺德任职外,朔尔茨先生还曾在麦肯锡和安徒生咨询公司任职。在担任这些职务期间,他对医疗保健和制药行业形成了独特的全球视野,扩展了他深厚的金融头脑,展示了对严格合规原则和执法的承诺,并监督了欧洲、北美和中东的业务运营和团队。他自2024年6月起担任特种化学品供应商Azelis Holding S.A.的董事、董事会主席和审计委员会成员。他此前于2021年2月至2023年3月期间担任国际香料香精公司的董事,该公司是香精、香料、食品配料以及健康和生物科学领域的全球领导者。他拥有哥本哈根大学经济学硕士学位。


Kre Schultz,has served on Board of Directors since July 2024. From November 2017 to January 2023, Mr. Schultz served as Chief Executive Officer and a director of Teva Pharmaceutical Industries Ltd. From 2015 to October 2017, Mr. Schultz served as the President and Chief Executive Officer of H. Lundbeck A/S. Prior to joining Lundbeck, Mr. Schultz worked for nearly three decades at Novo Nordisk, where he served in a number of leadership roles, including Chief Operating Officer, Vice President in Product Supply and Director of Product Planning and Customer Services in the Diabetes Care Division, and he played a major role in modernizing the company's large scale biologic production and leading the company's expansion into the US and Chinese markets. In addition to his time at Novo Nordisk, Mr. Schultz has held positions at McKinsey and Andersen Consulting. In these roles, he developed a unique global perspective on the healthcare and pharmaceutical industries, expanded his deep financial acumen, demonstrated a commitment to strong compliance principles and enforcement and oversaw business operations and teams across Europe and North America and the Middle East. He has served as a director, board chair and audit committee member of Azelis Holding S.A., a specialty chemical supplier, since June 2024. He previously served as a director of International Flavors & Fragrances, Inc., a global leader in flavors, fragrances, food ingredients and health and biosciences, from February 2021 through March 2023. He holds a master's degree in Economics from the University of Copenhagen.
K re Schultz,自2024年7月起担任董事会成员。2017年11月至2023年1月,Schultz先生担任梯瓦制药有限公司的首席执行官和董事。2015年至2017年10月,Schultz先生担任H. Lundbeck A/S总裁兼首席执行官。在加入Lundbeck之前,Schultz先生在诺和诺德工作了近三十年,担任过多个领导职务,包括糖尿病护理部门的首席运营官、产品供应副总裁以及产品规划和客户服务总监,他在公司大规模生物制剂生产的现代化和引领公司向美国和中国市场的扩张方面发挥了重要作用。除了在诺和诺德任职外,朔尔茨先生还曾在麦肯锡和安徒生咨询公司任职。在担任这些职务期间,他对医疗保健和制药行业形成了独特的全球视野,扩展了他深厚的金融头脑,展示了对严格合规原则和执法的承诺,并监督了欧洲、北美和中东的业务运营和团队。他自2024年6月起担任特种化学品供应商Azelis Holding S.A.的董事、董事会主席和审计委员会成员。他此前于2021年2月至2023年3月期间担任国际香料香精公司的董事,该公司是香精、香料、食品配料以及健康和生物科学领域的全球领导者。他拥有哥本哈根大学经济学硕士学位。
Kre Schultz,has served on Board of Directors since July 2024. From November 2017 to January 2023, Mr. Schultz served as Chief Executive Officer and a director of Teva Pharmaceutical Industries Ltd. From 2015 to October 2017, Mr. Schultz served as the President and Chief Executive Officer of H. Lundbeck A/S. Prior to joining Lundbeck, Mr. Schultz worked for nearly three decades at Novo Nordisk, where he served in a number of leadership roles, including Chief Operating Officer, Vice President in Product Supply and Director of Product Planning and Customer Services in the Diabetes Care Division, and he played a major role in modernizing the company's large scale biologic production and leading the company's expansion into the US and Chinese markets. In addition to his time at Novo Nordisk, Mr. Schultz has held positions at McKinsey and Andersen Consulting. In these roles, he developed a unique global perspective on the healthcare and pharmaceutical industries, expanded his deep financial acumen, demonstrated a commitment to strong compliance principles and enforcement and oversaw business operations and teams across Europe and North America and the Middle East. He has served as a director, board chair and audit committee member of Azelis Holding S.A., a specialty chemical supplier, since June 2024. He previously served as a director of International Flavors & Fragrances, Inc., a global leader in flavors, fragrances, food ingredients and health and biosciences, from February 2021 through March 2023. He holds a master's degree in Economics from the University of Copenhagen.
Patrick Carroll

Patrick Carroll,他于2022年2月加入董事会,目前担任首席医疗官,他于2022年12月重新加入该职位,此前他曾在Hims & Hers担任相同职务(从业务合并完成到2022年1月),并于2019年6月至2021年1月在Hims, Inc.担任相同职务。在此职位上,他负责监督与提供护理、临床结果、患者安全、医疗保健信息系统和战略举措和计划有关的所有事项,以增强hims&hers的护理模式。在重新加入hims&hers之前,从2022年2月到2022年10月,他担任Vida Health(一家虚拟护理公司,旨在共同治疗精神和身体状况)的首席医疗官;从2022年10月到2022年12月,他担任WHOOP(一家健康和健身可穿戴设备公司)的首席医疗官。Carroll博士于2014年5月至2019年6月担任Walgreens的集团副总裁兼首席医疗官。加入Walgreens之前,Carroll博士曾在Integrated Care Partners、Hartford HealthCare和Granite Medical Group担任各种职务。他在the College of the Holy Cross获得学士学位,在Dartmouth medical School获得医学学位。Carroll博士在家庭实践和青少年医学方面获得委员会认证。


Patrick Carroll,joined Board of Directors in February 2022 and is currently Chief Medical Officer, a role he re-joined in December 2022, after having served in the same role at Hims & Hers from the consummation of the Business Combination through January 2022 and at Hims, Inc. from June 2019 through January 2021. In this role, he oversees all matters pertaining to provision of care, clinical outcomes, patient safety, healthcare information systems and strategic initiatives and programs that enhance the Hims & Hers care model. Prior to rejoining Hims & Hers, he was the Chief Medical Officer of Vida Health, a virtual care company designed to treat mental and physical conditions together, from February 2022 through October 2022, and for WHOOP, a health and fitness wearables company, from October 2022 through December 2022. Dr. Carroll was the Group Vice President and Chief Medical Officer of Walgreens from May 2014 to June 2019. Prior to joining Walgreens, Dr. Carroll served in various roles at Integrated Care Partners, Hartford HealthCare and Granite Medical Group. Dr. Carroll received his bachelor's degree from the College of the Holy Cross and his medical degree from Dartmouth Medical School. Dr. Carroll is Board Certified in Family Practice and in Adolescent Medicine.
Patrick Carroll,他于2022年2月加入董事会,目前担任首席医疗官,他于2022年12月重新加入该职位,此前他曾在Hims & Hers担任相同职务(从业务合并完成到2022年1月),并于2019年6月至2021年1月在Hims, Inc.担任相同职务。在此职位上,他负责监督与提供护理、临床结果、患者安全、医疗保健信息系统和战略举措和计划有关的所有事项,以增强hims&hers的护理模式。在重新加入hims&hers之前,从2022年2月到2022年10月,他担任Vida Health(一家虚拟护理公司,旨在共同治疗精神和身体状况)的首席医疗官;从2022年10月到2022年12月,他担任WHOOP(一家健康和健身可穿戴设备公司)的首席医疗官。Carroll博士于2014年5月至2019年6月担任Walgreens的集团副总裁兼首席医疗官。加入Walgreens之前,Carroll博士曾在Integrated Care Partners、Hartford HealthCare和Granite Medical Group担任各种职务。他在the College of the Holy Cross获得学士学位,在Dartmouth medical School获得医学学位。Carroll博士在家庭实践和青少年医学方面获得委员会认证。
Patrick Carroll,joined Board of Directors in February 2022 and is currently Chief Medical Officer, a role he re-joined in December 2022, after having served in the same role at Hims & Hers from the consummation of the Business Combination through January 2022 and at Hims, Inc. from June 2019 through January 2021. In this role, he oversees all matters pertaining to provision of care, clinical outcomes, patient safety, healthcare information systems and strategic initiatives and programs that enhance the Hims & Hers care model. Prior to rejoining Hims & Hers, he was the Chief Medical Officer of Vida Health, a virtual care company designed to treat mental and physical conditions together, from February 2022 through October 2022, and for WHOOP, a health and fitness wearables company, from October 2022 through December 2022. Dr. Carroll was the Group Vice President and Chief Medical Officer of Walgreens from May 2014 to June 2019. Prior to joining Walgreens, Dr. Carroll served in various roles at Integrated Care Partners, Hartford HealthCare and Granite Medical Group. Dr. Carroll received his bachelor's degree from the College of the Holy Cross and his medical degree from Dartmouth Medical School. Dr. Carroll is Board Certified in Family Practice and in Adolescent Medicine.

高管简历

中英对照 |  中文 |  英文
Andrew Dudum

Andrew Dudum,自业务合并完成以来,Dudum先生一直担任我们的首席执行官和董事会主席。Dudum先生是HIMS的联合创始人,自2016年9月以来一直担任HIMS的首席执行官兼董事。Dudum先生是Startup Studio和投资基金Atomic Labs,LLC的联合创始人兼普通合伙人,自2013年以来,他在该公司联合创立了十几家公司,包括Bungalow,Homebound,Talkiq和Terminal。Dudum先生是一位连续创始人,活跃的天使投资者和各种创业公司的顾问。杜杜杜姆是总部位于中国和美国的早期风险投资公司Cherubic Ventures的顾问,并于2020年被《财富》杂志评为40岁以下40人名单。Dudum先生在宾夕法尼亚大学沃顿商学院获得管理和经济学学士学位。


Andrew Dudum,has served as Chief Executive Officer and Chairman of Board of Directors since the consummation of the business combination that resulted in Hims & Hers becoming a publicly traded company (the "Business Combination"). He is co-founder and has been the Chief Executive Officer and a director of Hims, Inc. since September 2016. Mr. Dudum is a co-founder of startup studio and investment fund Atomic Labs, LLC, since 2013, where he has co-founded over a dozen companies including Bungalow, Homebound, TalkIQ, and Terminal. He is a serial founder, active angel investor and advisor to various startup companies, including Cherubic Ventures, a China and U.S. based early-stage venture capital firm. Mr. Dudum received a B.A. in Management and Economics from the Wharton School at the University of Pennsylvania.
Andrew Dudum,自业务合并完成以来,Dudum先生一直担任我们的首席执行官和董事会主席。Dudum先生是HIMS的联合创始人,自2016年9月以来一直担任HIMS的首席执行官兼董事。Dudum先生是Startup Studio和投资基金Atomic Labs,LLC的联合创始人兼普通合伙人,自2013年以来,他在该公司联合创立了十几家公司,包括Bungalow,Homebound,Talkiq和Terminal。Dudum先生是一位连续创始人,活跃的天使投资者和各种创业公司的顾问。杜杜杜姆是总部位于中国和美国的早期风险投资公司Cherubic Ventures的顾问,并于2020年被《财富》杂志评为40岁以下40人名单。Dudum先生在宾夕法尼亚大学沃顿商学院获得管理和经济学学士学位。
Andrew Dudum,has served as Chief Executive Officer and Chairman of Board of Directors since the consummation of the business combination that resulted in Hims & Hers becoming a publicly traded company (the "Business Combination"). He is co-founder and has been the Chief Executive Officer and a director of Hims, Inc. since September 2016. Mr. Dudum is a co-founder of startup studio and investment fund Atomic Labs, LLC, since 2013, where he has co-founded over a dozen companies including Bungalow, Homebound, TalkIQ, and Terminal. He is a serial founder, active angel investor and advisor to various startup companies, including Cherubic Ventures, a China and U.S. based early-stage venture capital firm. Mr. Dudum received a B.A. in Management and Economics from the Wharton School at the University of Pennsylvania.
Melissa Baird

Melissa Baird,自业务合并完成以来,Baird女士一直担任我们的首席运营官。Baird女士自2018年2月起担任HIMS’;首席运营官。在担任HIMS首席运营官之前,Baird女士于2016年7月至2018年1月担任Draper James的系统和程序副总裁。从2015年12月到2016年7月,Baird女士担任OneFinestay的总经理。在此之前,Baird女士从2013年9月到2015年11月在Bonobos工作,最终担任运营和产品管理副总裁。任职期间,她负责与网站、电子商务平台、产品管理、履行和客户服务相关的战略。从2011年5月到2013年9月,Baird女士担任Zulily的供应链运营产品经理,负责通过技术计划将Zulily’;的履行运营和扩展运营内部化。从2001年1月到2011年5月,Baird女士担任过各种科学研究职务,从实验室技术员到遗传学家。Baird女士在密苏里大学获得生物科学学士学位。


Melissa Baird,has served as Chief Operating Officer since the consummation of the Business Combination and has held the same role at Hims, Inc. since February 2018. Ms. Baird hass more than a dozen years of operations and technology management in the consumer space as well as over 10 years of scientific research experience. Prior to serving as Chief Operating Officer, from July 2016 to January 2018 Ms. Baird was Vice President of Systems and Procedures for Draper James. From December 2015 to July 2016, Ms. Baird served as the General Manager of Onefinestay. Prior to that, Ms. Baird was with Bonobos from September 2013 to November 2015, ultimately serving as the Vice President of Operations and Product Management. From May 2011 to September 2013, Ms. Baird served as the Product Manager of Supply Chain Operations for Zulily, with responsibility for hasing Zulily's fulfillment operations in-house and scaling operations through technology programs. Previously, Ms. Baird held a variety of scientific research roles at the University of Washington and the National Oceanic and Atmospheric Administration, ranging from Lab Technician to Geneticist. Ms. Baird obtained a B.S. in Biological Sciences from the University of Missouri.
Melissa Baird,自业务合并完成以来,Baird女士一直担任我们的首席运营官。Baird女士自2018年2月起担任HIMS’;首席运营官。在担任HIMS首席运营官之前,Baird女士于2016年7月至2018年1月担任Draper James的系统和程序副总裁。从2015年12月到2016年7月,Baird女士担任OneFinestay的总经理。在此之前,Baird女士从2013年9月到2015年11月在Bonobos工作,最终担任运营和产品管理副总裁。任职期间,她负责与网站、电子商务平台、产品管理、履行和客户服务相关的战略。从2011年5月到2013年9月,Baird女士担任Zulily的供应链运营产品经理,负责通过技术计划将Zulily’;的履行运营和扩展运营内部化。从2001年1月到2011年5月,Baird女士担任过各种科学研究职务,从实验室技术员到遗传学家。Baird女士在密苏里大学获得生物科学学士学位。
Melissa Baird,has served as Chief Operating Officer since the consummation of the Business Combination and has held the same role at Hims, Inc. since February 2018. Ms. Baird hass more than a dozen years of operations and technology management in the consumer space as well as over 10 years of scientific research experience. Prior to serving as Chief Operating Officer, from July 2016 to January 2018 Ms. Baird was Vice President of Systems and Procedures for Draper James. From December 2015 to July 2016, Ms. Baird served as the General Manager of Onefinestay. Prior to that, Ms. Baird was with Bonobos from September 2013 to November 2015, ultimately serving as the Vice President of Operations and Product Management. From May 2011 to September 2013, Ms. Baird served as the Product Manager of Supply Chain Operations for Zulily, with responsibility for hasing Zulily's fulfillment operations in-house and scaling operations through technology programs. Previously, Ms. Baird held a variety of scientific research roles at the University of Washington and the National Oceanic and Atmospheric Administration, ranging from Lab Technician to Geneticist. Ms. Baird obtained a B.S. in Biological Sciences from the University of Missouri.
Soleil Boughton

Soleil Boughton,自业务合并完成以来,Boughton女士一直担任我们的首席法务官和公司秘书。Boughton女士于2018年10月加入HIMS,负责公司的法律部门和公共政策活动,目前担任首席法律官兼公司秘书。Boughton女士于2017年10月至2018年10月担任谷歌云医疗保健和生命科学的内部医疗保健顾问。在此之前,Boughton女士于2015年1月至2017年10月担任众达医疗保健与生命科学集团的合伙人,主要代表直接面向消费者的远程医疗和其他数字健康公司。Boughton女士在波莫纳学院获得学士学位,并在加州大学洛杉矶分校法学院获得法学博士学位。


Soleil Boughton,has served as Chief Legal Officer and Corporate Secretary since the consummation of the Business Combination. Ms. Boughton joined Hims, Inc. in October 2018 to oversee the company's legal department and public policy activities. Ms. Boughton hass over 20 years of healthcare law experience to the Company, and has represented digital health companies, hospitals, health systems and other healthcare and life sciences companies across all aspects of a company's life cycle. Ms. Boughton was in-house healthcare counsel for Google's Cloud Healthcare & Life Sciences from October 2017 to October 2018. Ms. Boughton was a Partner in the Healthcare & Life Sciences group of Jones Day from January 2015 to October 2017, where she primarily represented direct-to-consumer telehealth and other digital health companies. Ms. Boughton previously served as a member of the board of directors of CaringBridge, a 501(c)(3) nonprofit organization. Ms. Boughton obtained a B.A. from Pomona College and a J.D. from the UCLA School of Law.
Soleil Boughton,自业务合并完成以来,Boughton女士一直担任我们的首席法务官和公司秘书。Boughton女士于2018年10月加入HIMS,负责公司的法律部门和公共政策活动,目前担任首席法律官兼公司秘书。Boughton女士于2017年10月至2018年10月担任谷歌云医疗保健和生命科学的内部医疗保健顾问。在此之前,Boughton女士于2015年1月至2017年10月担任众达医疗保健与生命科学集团的合伙人,主要代表直接面向消费者的远程医疗和其他数字健康公司。Boughton女士在波莫纳学院获得学士学位,并在加州大学洛杉矶分校法学院获得法学博士学位。
Soleil Boughton,has served as Chief Legal Officer and Corporate Secretary since the consummation of the Business Combination. Ms. Boughton joined Hims, Inc. in October 2018 to oversee the company's legal department and public policy activities. Ms. Boughton hass over 20 years of healthcare law experience to the Company, and has represented digital health companies, hospitals, health systems and other healthcare and life sciences companies across all aspects of a company's life cycle. Ms. Boughton was in-house healthcare counsel for Google's Cloud Healthcare & Life Sciences from October 2017 to October 2018. Ms. Boughton was a Partner in the Healthcare & Life Sciences group of Jones Day from January 2015 to October 2017, where she primarily represented direct-to-consumer telehealth and other digital health companies. Ms. Boughton previously served as a member of the board of directors of CaringBridge, a 501(c)(3) nonprofit organization. Ms. Boughton obtained a B.A. from Pomona College and a J.D. from the UCLA School of Law.
Yemi Okupe

叶米·奥库佩,2022年1月加入公司担任首席财务官。在加入公司之前,Okupe先生于2021年6月至2022年1月担任海马汽车的首席财务官。他曾于2020年3月至2021年6月担任部门CFO,Uber Mobility,并于2019年6月至2020年3月担任部门CFO,Uber Eats。此前,Okupe先生于2017年3月至2019年6月担任PayPal旗下部门Braintree Payment Solutions LLC的部门CFO,并于2016年4月至2017年3月担任Braintree财务规划和分析主管。在此之前,奥库佩先生曾于2014年至2016年在谷歌担任Google Commerce的财务主管,并于2011年至2014年在eBay和eBay的一个部门PayPal担任过多个财务职务。奥库佩先生是一名特许金融分析师特许持有人,并在伊利诺伊州获得注册会计师执照。他拥有斯坦福大学商学院的工商管理硕士学位和加州大学戴维斯分校的土木工程学士学位。


Yemi Okupe,joined the Company as Chief Financial Officer in January 2022. Prior to joining the Company, Mr. Okupe served as Chief Financial Officer of Hipcamp from June 2021 to January 2022. He served as Divisional CFO, Mobility of Uber from March 2020 to June 2021 and as Divisional CFO, Uber Eats from June 2019 to March 2020. Previously, Mr. Okupe served as Divisional CFO for Braintree Payment Solutions LLC, a division of PayPal, from March 2017 to June 2019 and as Head of Financial Planning and Analysis, Braintree from April 2016 to March 2017. Prior to that, Mr. Okupe was Finance Lead, Google Commerce at Google from 2014 to 2016 and served in various finance roles at eBay and PayPal, a division of eBay, from 2011 to 2014. Mr. Okupe is a Chartered Financial Analyst charterholder and is also licensed as a Certified Public Accountant in Illinois. He holds an M.B.A. from Stanford University Graduate School of Business and a bachelor's degree in civil engineering from the University of California, Davis.
叶米·奥库佩,2022年1月加入公司担任首席财务官。在加入公司之前,Okupe先生于2021年6月至2022年1月担任海马汽车的首席财务官。他曾于2020年3月至2021年6月担任部门CFO,Uber Mobility,并于2019年6月至2020年3月担任部门CFO,Uber Eats。此前,Okupe先生于2017年3月至2019年6月担任PayPal旗下部门Braintree Payment Solutions LLC的部门CFO,并于2016年4月至2017年3月担任Braintree财务规划和分析主管。在此之前,奥库佩先生曾于2014年至2016年在谷歌担任Google Commerce的财务主管,并于2011年至2014年在eBay和eBay的一个部门PayPal担任过多个财务职务。奥库佩先生是一名特许金融分析师特许持有人,并在伊利诺伊州获得注册会计师执照。他拥有斯坦福大学商学院的工商管理硕士学位和加州大学戴维斯分校的土木工程学士学位。
Yemi Okupe,joined the Company as Chief Financial Officer in January 2022. Prior to joining the Company, Mr. Okupe served as Chief Financial Officer of Hipcamp from June 2021 to January 2022. He served as Divisional CFO, Mobility of Uber from March 2020 to June 2021 and as Divisional CFO, Uber Eats from June 2019 to March 2020. Previously, Mr. Okupe served as Divisional CFO for Braintree Payment Solutions LLC, a division of PayPal, from March 2017 to June 2019 and as Head of Financial Planning and Analysis, Braintree from April 2016 to March 2017. Prior to that, Mr. Okupe was Finance Lead, Google Commerce at Google from 2014 to 2016 and served in various finance roles at eBay and PayPal, a division of eBay, from 2011 to 2014. Mr. Okupe is a Chartered Financial Analyst charterholder and is also licensed as a Certified Public Accountant in Illinois. He holds an M.B.A. from Stanford University Graduate School of Business and a bachelor's degree in civil engineering from the University of California, Davis.
Mike Chi

Mike Chi,首席商务官,于2021年4月加入HIMS & Hers。他负责市场营销、产品管理、品类管理和国际。Chi先生在增长营销、品牌定位、产品管理、销售和战略方面带来了超过20年的消费互联网经验。在加入HIMS & Hers之前,Chi先生在2017年6月至2021年4月期间担任Zola(一套数字婚礼策划工具)的首席营销官,在那里他领导了公司营销、创意和传播的各个方面,并担任公司策划工具的总经理。2015年9月至2017年6月,他担任女性奢侈时尚零售商INTERMIX的营销和电子商务副总裁,领导营销、创意、产品管理和电子商务运营。Chi先生还在2010年10月至2015年9月期间担任在线购物和生活方式公司Gilt Groupe的高级副总裁兼总经理女装。在任职于Gilt之前,Chi先生曾在波士顿咨询公司、The Children's Place和Gap Inc担任过各种职务。他拥有哥伦比亚商学院的工商管理硕士学位和布朗大学的学士学位。


Mike Chi,is Chief Commercial Officer and joined Hims & Hers in April 2021. He oversees marketing, product management, category management and international. Mr Chi hass over 20 years of experience in consumer internet across growth marketing, brand positioning, product management, merchandising and strategy. Prior to joining Hims & Hers, Mr. Chi was the Chief Marketing Officer at Zola, a suite of digital wedding planning tools, from June 2017 through April 2021, where he led all aspects of the company's marketing, creative and communications as well as acting as GM for the company's planning tools. He was Vice President of Marketing and Ecommerce for INTERMIX, a women's luxury fashion retailer, from September 2015 through June 2017, leading marketing, creative, product management and e-commerce operations. Mr. Chi was also SVP, General Manager Women's at Gilt Groupe, an online shopping and lifestyle company, from October 2010 through September 2015. Prior to his tenure at Gilt, Mr. Chi served in various roles at Boston Consulting Group, the Children's Place and Gap Inc. He holds an M.B.A. from Columbia Business School and a B.A. from Brown University.
Mike Chi,首席商务官,于2021年4月加入HIMS & Hers。他负责市场营销、产品管理、品类管理和国际。Chi先生在增长营销、品牌定位、产品管理、销售和战略方面带来了超过20年的消费互联网经验。在加入HIMS & Hers之前,Chi先生在2017年6月至2021年4月期间担任Zola(一套数字婚礼策划工具)的首席营销官,在那里他领导了公司营销、创意和传播的各个方面,并担任公司策划工具的总经理。2015年9月至2017年6月,他担任女性奢侈时尚零售商INTERMIX的营销和电子商务副总裁,领导营销、创意、产品管理和电子商务运营。Chi先生还在2010年10月至2015年9月期间担任在线购物和生活方式公司Gilt Groupe的高级副总裁兼总经理女装。在任职于Gilt之前,Chi先生曾在波士顿咨询公司、The Children's Place和Gap Inc担任过各种职务。他拥有哥伦比亚商学院的工商管理硕士学位和布朗大学的学士学位。
Mike Chi,is Chief Commercial Officer and joined Hims & Hers in April 2021. He oversees marketing, product management, category management and international. Mr Chi hass over 20 years of experience in consumer internet across growth marketing, brand positioning, product management, merchandising and strategy. Prior to joining Hims & Hers, Mr. Chi was the Chief Marketing Officer at Zola, a suite of digital wedding planning tools, from June 2017 through April 2021, where he led all aspects of the company's marketing, creative and communications as well as acting as GM for the company's planning tools. He was Vice President of Marketing and Ecommerce for INTERMIX, a women's luxury fashion retailer, from September 2015 through June 2017, leading marketing, creative, product management and e-commerce operations. Mr. Chi was also SVP, General Manager Women's at Gilt Groupe, an online shopping and lifestyle company, from October 2010 through September 2015. Prior to his tenure at Gilt, Mr. Chi served in various roles at Boston Consulting Group, the Children's Place and Gap Inc. He holds an M.B.A. from Columbia Business School and a B.A. from Brown University.
Patrick Carroll

Patrick Carroll,他于2022年2月加入董事会,目前担任首席医疗官,他于2022年12月重新加入该职位,此前他曾在Hims & Hers担任相同职务(从业务合并完成到2022年1月),并于2019年6月至2021年1月在Hims, Inc.担任相同职务。在此职位上,他负责监督与提供护理、临床结果、患者安全、医疗保健信息系统和战略举措和计划有关的所有事项,以增强hims&hers的护理模式。在重新加入hims&hers之前,从2022年2月到2022年10月,他担任Vida Health(一家虚拟护理公司,旨在共同治疗精神和身体状况)的首席医疗官;从2022年10月到2022年12月,他担任WHOOP(一家健康和健身可穿戴设备公司)的首席医疗官。Carroll博士于2014年5月至2019年6月担任Walgreens的集团副总裁兼首席医疗官。加入Walgreens之前,Carroll博士曾在Integrated Care Partners、Hartford HealthCare和Granite Medical Group担任各种职务。他在the College of the Holy Cross获得学士学位,在Dartmouth medical School获得医学学位。Carroll博士在家庭实践和青少年医学方面获得委员会认证。


Patrick Carroll,joined Board of Directors in February 2022 and is currently Chief Medical Officer, a role he re-joined in December 2022, after having served in the same role at Hims & Hers from the consummation of the Business Combination through January 2022 and at Hims, Inc. from June 2019 through January 2021. In this role, he oversees all matters pertaining to provision of care, clinical outcomes, patient safety, healthcare information systems and strategic initiatives and programs that enhance the Hims & Hers care model. Prior to rejoining Hims & Hers, he was the Chief Medical Officer of Vida Health, a virtual care company designed to treat mental and physical conditions together, from February 2022 through October 2022, and for WHOOP, a health and fitness wearables company, from October 2022 through December 2022. Dr. Carroll was the Group Vice President and Chief Medical Officer of Walgreens from May 2014 to June 2019. Prior to joining Walgreens, Dr. Carroll served in various roles at Integrated Care Partners, Hartford HealthCare and Granite Medical Group. Dr. Carroll received his bachelor's degree from the College of the Holy Cross and his medical degree from Dartmouth Medical School. Dr. Carroll is Board Certified in Family Practice and in Adolescent Medicine.
Patrick Carroll,他于2022年2月加入董事会,目前担任首席医疗官,他于2022年12月重新加入该职位,此前他曾在Hims & Hers担任相同职务(从业务合并完成到2022年1月),并于2019年6月至2021年1月在Hims, Inc.担任相同职务。在此职位上,他负责监督与提供护理、临床结果、患者安全、医疗保健信息系统和战略举措和计划有关的所有事项,以增强hims&hers的护理模式。在重新加入hims&hers之前,从2022年2月到2022年10月,他担任Vida Health(一家虚拟护理公司,旨在共同治疗精神和身体状况)的首席医疗官;从2022年10月到2022年12月,他担任WHOOP(一家健康和健身可穿戴设备公司)的首席医疗官。Carroll博士于2014年5月至2019年6月担任Walgreens的集团副总裁兼首席医疗官。加入Walgreens之前,Carroll博士曾在Integrated Care Partners、Hartford HealthCare和Granite Medical Group担任各种职务。他在the College of the Holy Cross获得学士学位,在Dartmouth medical School获得医学学位。Carroll博士在家庭实践和青少年医学方面获得委员会认证。
Patrick Carroll,joined Board of Directors in February 2022 and is currently Chief Medical Officer, a role he re-joined in December 2022, after having served in the same role at Hims & Hers from the consummation of the Business Combination through January 2022 and at Hims, Inc. from June 2019 through January 2021. In this role, he oversees all matters pertaining to provision of care, clinical outcomes, patient safety, healthcare information systems and strategic initiatives and programs that enhance the Hims & Hers care model. Prior to rejoining Hims & Hers, he was the Chief Medical Officer of Vida Health, a virtual care company designed to treat mental and physical conditions together, from February 2022 through October 2022, and for WHOOP, a health and fitness wearables company, from October 2022 through December 2022. Dr. Carroll was the Group Vice President and Chief Medical Officer of Walgreens from May 2014 to June 2019. Prior to joining Walgreens, Dr. Carroll served in various roles at Integrated Care Partners, Hartford HealthCare and Granite Medical Group. Dr. Carroll received his bachelor's degree from the College of the Holy Cross and his medical degree from Dartmouth Medical School. Dr. Carroll is Board Certified in Family Practice and in Adolescent Medicine.